Home/Filings/4/0001209191-08-067407
4//SEC Filing

BARR PHARMACEUTICALS INC 4

Accession 0001209191-08-067407

CIK 0000010081operating

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 9:19 AM ET

Size

27.7 KB

Accession

0001209191-08-067407

Insider Transaction Report

Form 4
Period: 2008-12-23
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-2310,0000 total
    Exercise: $57.35From: 2006-11-03Exp: 2015-11-03Common Stock (10,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-2311,2500 total
    Exercise: $49.02From: 2004-10-23Exp: 2013-10-23Common Stock (11,250 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-237,5000 total
    Exercise: $37.87From: 2005-10-28Exp: 2014-10-28Common Stock (7,500 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-2316,8750 total
    Exercise: $33.70From: 2002-10-25Exp: 2011-10-25Common Stock (16,875 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-235,0000 total
    Exercise: $54.25From: 2008-05-17Exp: 2017-05-17Common Stock (5,000 underlying)
  • Disposition to Issuer

    Common Stock

    2008-12-2311,8750 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2008-12-2311,8750 total
    Exercise: $28.14From: 2001-10-26Exp: 2010-10-26Common Stock (11,875 underlying)
Footnotes (10)
  • [F1]Disposed of pursuant to a merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 7,448 shares of Teva Common Stock having a market value of $41.82 per share on the effective date of the merger and cash in the amount of $473,812.50.
  • [F10]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $25.14 per share.
  • [F2]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 18,777 shares of Common Stock of Teva for an exercise price of $17.80 per share.
  • [F3]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 26,684 shares of Common Stock of Teva for an exercise price of $16.92 per share.
  • [F4]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 26,684 shares of Common Stock of Teva for an exercise price of $21.31 per share.
  • [F5]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 17,789 shares of Common Stock of Teva for an exercise price of $31.00 per share.
  • [F6]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 11,859 shares of Common Stock of Teva for an exercise price of $23.95 per share.
  • [F7]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $36.27 per share.
  • [F8]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $30.89 per share.
  • [F9]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 7,906 shares of Common Stock of Teva for an exercise price of $34.31 per share.

Issuer

BARR PHARMACEUTICALS INC

CIK 0000010081

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000010081

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 9:19 AM ET
Size
27.7 KB